Matches in Ubergraph for { <http://purl.obolibrary.org/obo/NCIT_C182628> ?p ?o ?g. }
Showing items 1 to 22 of
22
with 100 items per page.
- NCIT_C182628 IAO_0000115 "A vaccine comprised of a recombinant modified Vaccinia virus Ankara (MVA) viral vector expressing full-length severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) surface antigen spike (S) protein, with potential immunizing activity against SARS-CoV-2. Upon administration of the MVA-based SARS-CoV-2 Vaccine MVA-SARS-2-S, the SARS-CoV-2 S protein is presented to the immune system. This may activate both humoral and cellular immune responses which may result in protection against SARS-CoV-2 infection." @default.
- NCIT_C182628 NCIT_NHC0 "C182628" @default.
- NCIT_C182628 NCIT_P106 "Pharmacologic Substance" @default.
- NCIT_C182628 NCIT_P108 "MVA-based SARS-CoV-2 Vaccine MVA-SARS-2-S" @default.
- NCIT_C182628 NCIT_P208 "CL1770957" @default.
- NCIT_C182628 normalizedInformationContent "100" @default.
- NCIT_C182628 referenceCount "1" @default.
- NCIT_C182628 hasExactSynonym "MVA-SARS-2-S" @default.
- NCIT_C182628 hasExactSynonym "MVA-based Covid-19 Vaccine MVA-SARS-2-S" @default.
- NCIT_C182628 hasExactSynonym "MVA-based SARS-CoV-2 Vaccine MVA-SARS-2-S" @default.
- NCIT_C182628 inSubset NCIT_C173381 @default.
- NCIT_C182628 inSubset NCIT_C173383 @default.
- NCIT_C182628 type Class @default.
- NCIT_C182628 isDefinedBy ncit.owl @default.
- NCIT_C182628 label "MVA-based SARS-CoV-2 Vaccine MVA-SARS-2-S" @default.
- NCIT_C182628 subClassOf NCIT_C173023 @default.
- NCIT_C182628 subClassOf NCIT_C182628 @default.
- NCIT_C182628 subClassOf NCIT_C1908 @default.
- NCIT_C182628 subClassOf NCIT_C1909 @default.
- NCIT_C182628 subClassOf NCIT_C307 @default.
- NCIT_C182628 subClassOf NCIT_C308 @default.
- NCIT_C182628 subClassOf NCIT_C923 @default.